VentriPoint Diagnostics
Using Artificial Intelligence to create 3D volumetric measurements from standard 2D Echo images for peds and adults.
Launch date
Employees
Market cap
CAD30.7m
Enterprise valuation
CAD32m (Public information from Sep 2024)
Share price
CAD0.17 VPT.V
Toronto Ontario (HQ)
Financials
Estimates*
| CAD | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|
| Revenues | <1m | <1m | <1m | <1m | - | <1m | <1m |
| % growth | - | 55 % | 35 % | (56 %) | - | - | (28 %) |
| EBITDA | (3.7m) | (3.8m) | (3.1m) | (1.6m) | (3.5m) | (4.7m) | (4.7m) |
| % EBITDA margin | (9403 %) | (6304 %) | (3865 %) | (4416 %) | - | (6944 %) | (9619 %) |
| Profit | (3.7m) | (2.1m) | (3.3m) | (1.9m) | (3.9m) | (4.9m) | (4.9m) |
| % profit margin | (9520 %) | (3462 %) | (4101 %) | (5138 %) | - | (7148 %) | (9906 %) |
| EV / revenue | 376.1x | 153.7x | 78.0x | 246.5x | - | 551.9x | 922.7x |
| EV / EBITDA | -4.0x | -2.4x | -2.0x | -5.6x | -12.6x | -8.0x | -9.6x |
| R&D budget | 1.2m | 1.5m | 1.0m | <1m | <1m | 1.1m | 1.1m |
| R&D % of revenue | 3031 % | 2409 % | 1289 % | 755 % | - | 1541 % | 2203 % |
| Date | Investors | Amount | Round |
|---|---|---|---|
| N/A | N/A | IPO | |
| N/A | $138k | Post IPO Equity | |
| N/A | $97.7k | Post IPO Equity | |
| N/A | $1.5m | Post IPO Equity | |
| N/A | $1.2m | Post IPO Equity | |
| N/A | $265k | Post IPO Equity | |
| N/A | $748k | Post IPO Debt | |
| N/A | $250k | Post IPO Debt | |
| N/A | $800k | Post IPO Equity | |
| N/A | $600k | Post IPO Equity | |
$160k | Post IPO Debt | ||
$120k | Grant | ||
| Total Funding | CAD164k | ||
Related Content
Recent News about VentriPoint Diagnostics
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.